Saluda Medical Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Revenue	90.18	70.36	51.68	22.23
Revenue Growth	28.17%	36.13%	132.45%	-
Cost of Revenue	46.09	37.6	28.57	18.2
Gross Profit	44.08	32.76	23.11	4.04
Selling, General & Admin	154.31	115.35	93.05	68.15
Research & Development	34.24	35.46	29.2	28.11
Other Operating Expenses	4.52	-	-	-
Operating Expenses	193.08	150.81	122.25	96.26
Operating Income	-148.99	-118.05	-99.14	-92.22
Interest Expense	-9.42	-27.24	-5	-4.67
Interest & Investment Income	2.68	2.01	5.47	3.21
Currency Exchange Gain (Loss)	-0.2	1.65	0.11	1.43
Other Non Operating Income (Expenses)	7.08	-7.15	1	0.7
Pretax Income	-148.87	-148.77	-97.55	-91.55
Income Tax Expense	0.7	0.53	0.27	0.61
Net Income	-149.57	-149.3	-97.83	-92.16
Net Income to Common	-149.57	-149.3	-97.83	-92.16
Net Income Growth	-	-	-	-
Shares Outstanding (Basic)	162	3	3	3
Shares Outstanding (Diluted)	162	3	3	3
Shares Change	4886.98%	0.13%	0.06%	-
EPS (Basic)	-0.92	-45.92	-30.13	-28.40
EPS (Diluted)	-1.48	-45.92	-30.13	-28.40
EPS Growth	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Free Cash Flow	-116.72	-119.51	-94.4	-88.03
Free Cash Flow Per Share	-0.72	-36.75	-29.07	-27.13
Gross Margin	48.89%	46.56%	44.72%	18.17%
Operating Margin	-165.23%	-167.79%	-191.82%	-414.78%
Profit Margin	-165.87%	-212.21%	-189.29%	-414.52%
Free Cash Flow Margin	-129.44%	-169.87%	-182.66%	-395.93%
EBITDA	-147.19	-116.4	-97.25	-90.94
EBITDA Margin	-163.22%	-165.45%	-188.17%	-
D&A For EBITDA	1.81	1.65	1.89	1.29
EBIT	-148.99	-118.05	-99.14	-92.22
EBIT Margin	-165.23%	-167.79%	-191.82%	-